Role of the plasminogen system in basal adhesion formation and carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice

被引:48
作者
Molinas, CR
Elkelani, O
Campo, R
Luttun, A
Carmeliet, P
Koninckx, PR
机构
[1] Univ Hosp Gasthuisberg, Dept Obstet & Gynecol, B-3000 Louvain, Belgium
[2] Katholieke Univ Leuven, Ctr Surg Technol, Louvain, Belgium
[3] Katholieke Univ Leuven, Univ Hosp Gasthuisberg, Dept Obstet & Gynecol, B-3000 Louvain, Belgium
[4] Leuven Inst Fertil & Embryol, Louvain, Belgium
[5] Katholieke Univ Leuven, Interuniv Inst Biotechnol, Ctr Transgene Technol & Gene Therapy, Louvain, Belgium
关键词
adhesion formation; laparoscopy; CO2; pneumoperitoneum; plasminogen activator inhibitor-1; urokinase-type plasminogen activator; and tissue-type plasminogen activator; transgenic mice;
D O I
10.1016/S0015-0282(03)00496-5
中图分类号
R71 [妇产科学];
学科分类号
100211 [妇产科学];
摘要
Objective: To evaluate the role of plasminogen activator inhibitor-1 (PAI- 1), urokinase plasminogen activator (uPA), and tissue-type plasminogen activator (tPA) in adhesion formation after laparoscopic surgery. Design: Prospective, randomized study. Setting: Academic research center. Animal(s): Seventy female wild-type and transgenic knockout mice for PAI-1 (PAI-1(-/-)), uPA (uPA(-/-)) or tPA (tPA(-/-)). Intervention(s): Standardized lesions to induce peritoneal adhesions were performed during laparoscopy. To evaluate basal adhesions and pneumoperitoneum-enhanced adhesions, the pneumoperitoneum was maintained for 10 minutes or 60 minutes, respectively. Peritoneal biopsy samples were obtained during and after 60 minutes of carbon dioxide prieumoperitoneum. Main Outcome Measure(s): Adhesions were blindly scored after 7 days. Concentrations of PAI-1 and tPA were measured by using enzyme-linked immunosorbent assay. Result(s): In PAI-1, uPA, and tPA wild-type mice, pneumoperitoneum, enhanced adhesions. Compared with wild-type mice, basal adhesions were fewer in PAI-1(-/-) mice and more in uPA(-/-) and tPA(-/-) mice. Pneumoperitoneum did not enhance adhesions in these transgenic mice. PAI-1 concentration increased after 60 minutes of pneumoperitoneum whereas tPA concentration did not change. Conclusion(s): Impaired fibrinolysis increases basal adhesions. The absence of pneumoperitoneum-enhanced adhesions in PAI-1(-/-), uPA(-/-), and tPA(-/-) mice and the increase in PAI-1 expression indicate that PAI-1 up-regulation by carbon dioxide pneumoperitoneum is a mechanism of pneumoperitoneum-enhanced adhesion formation. (C)2003 by American Society for Reproductive Medicine.
引用
收藏
页码:184 / 192
页数:9
相关论文
共 82 条
[1]
Peritoneal and systemic cytokine response to laparotomy [J].
Badia, JM ;
Whawell, SA ;
ScottCoombes, DM ;
Abel, PD ;
Williamson, RCN ;
Thompson, JN .
BRITISH JOURNAL OF SURGERY, 1996, 83 (03) :347-348
[2]
PROTEASE-NEXIN - A CELLULAR-COMPONENT THAT LINKS THROMBIN AND PLASMINOGEN-ACTIVATOR AND MEDIATES THEIR BINDING TO CELLS [J].
BAKER, JB ;
LOW, DA ;
SIMMER, RL ;
CUNNINGHAM, DD .
CELL, 1980, 21 (01) :37-45
[3]
Brass DM, 2001, EXP LUNG RES, V27, P639
[4]
PHYSIOLOGICAL CONSEQUENCES OF LOSS OF PLASMINOGEN-ACTIVATOR GENE-FUNCTION IN MICE [J].
CARMELIET, P ;
SCHOONJANS, L ;
KIECKENS, L ;
REAM, B ;
DEGEN, J ;
BRONSON, R ;
DEVOS, R ;
VANDENOORD, JJ ;
COLLEN, D ;
MULLIGAN, RC .
NATURE, 1994, 368 (6470) :419-424
[5]
Carmeliet P, 1997, CIRC RES, V81, P829
[6]
PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .2. EFFECTS ON HEMOSTASIS, THROMBOSIS, AND THROMBOLYSIS [J].
CARMELIET, P ;
STASSEN, JM ;
SCHOONJANS, L ;
REAM, B ;
VANDENOORD, JJ ;
DEMOL, M ;
MULLIGAN, RC ;
COLLEN, D .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2756-2760
[7]
PLASMINOGEN-ACTIVATOR INHIBITOR-1 GENE DEFICIENT MICE .1. GENERATION BY HOMOLOGOUS RECOMBINATION AND CHARACTERIZATION [J].
CARMELIET, P ;
KIECKENS, L ;
SCHOONJANS, L ;
REAM, B ;
VANNUFFELEN, A ;
PRENDERGAST, G ;
COLE, M ;
BRONSON, R ;
COLLEN, D ;
MULLIGAN, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (06) :2746-2755
[8]
The human fibrinolytic system [J].
Chandler, WL .
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 1996, 24 (01) :27-45
[9]
Chegini N, 1997, EUR J SURG, V163, P17
[10]
TISSUE-TYPE PLASMINOGEN-ACTIVATOR - A REVIEW OF ITS PHARMACOLOGY AND THERAPEUTIC USE AS A THROMBOLYTIC AGENT [J].
COLLEN, D ;
LIJNEN, HR ;
TODD, PA ;
GOA, KL .
DRUGS, 1989, 38 (03) :346-388